Summary:
Click image to enlargeA compensated Phase 1 study that will examine the safetiness of a new malaria vaccine.
Qualified Participants Must:
Be between the ages of 18-55 years old
Be willing and able to participate in all planned study visits for the duration of the study
Be in good health
Be of low cardiac risk
Agree not to travel to places where there is malaria during the time of the study
Be a male or non-pregnant, Non-breastfeeding female